legal-news

2:25-cv-15123 ARS PHARMACEUTICALS OPERATIONS, INC. et al v. LUPIN INC. et al

25-cv-15123 Filed
Active Active litigation Sign in to follow this case
Share mail
Advertisement
description

Case Summary

This civil case features plaintiffs ARS Pharmaceuticals Operations, Inc. and others against defendants Lupin Inc. and others. The docket references an order, but no further substantive details or case context are provided. The nature of the dispute likely involves pharmaceutical or commercial issues given the parties involved.

Stage

Active litigation

Timeline

3 events

Coverage

3 articles

Sources

1

Key Issues

  • Pharmaceutical litigation
  • Court orders
  • Civil procedure
Advertisement

Case Timeline

3 events
info
Other April 14, 2026

1:25-cv-00757 Indivior Inc. v. Lupin Inc. et al

In the case involving ARS Pharmaceuticals and Lupin Inc., the court adjusted the deadline for Lupin Inc. and others to submit their formal response to the lawsuit filed by Indivior Inc. This change gives the defendants more time to prepare their answer, which is a critical step in the legal process. It ensures that both parties have a fair opportunity to present their positions.

gavel
Order April 14, 2026

2:26-cv-02036 ARS PHARMACEUTICALS OPERATIONS, INC. et al v. LUPIN INC. et al

The court issued an order in the case involving ARS Pharmaceuticals Operations, Inc. and Lupin Inc., which is related to a similar case with a different docket number. This order likely addresses procedural or substantive matters that affect how the case will proceed. Such orders help clarify the court's stance and guide the next steps for both parties.

gavel
Order April 14, 2026

2:25-cv-15123 ARS PHARMACEUTICALS OPERATIONS, INC. et al v. LUPIN INC. et al

The court issued an order in the case between ARS Pharmaceuticals Operations, Inc. and Lupin Inc. This order represents a formal decision or directive from the judge regarding a specific matter in the lawsuit. Such orders help guide the progress of the case and clarify the court's stance on key issues.

Advertisement
newspaper

Press Coverage

3 articles